当前位置:首页 - 行情中心 - 同和药业(300636) - 财务分析

同和药业

(300636)

  

流通市值:27.77亿  总市值:31.75亿
流通股本:3.67亿   总股本:4.20亿

同和药业(300636)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.21亿元,每股收益0.05元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益232952.93万元,未分配利润59603.37万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产342128.72万元,负债109175.79万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入186,897,547.53758,890,499.03569,933,408.38382,051,594.68
营业总成本161,677,017.83626,890,162.6455,177,777.45295,168,592.6
营业利润22,045,134.74111,400,839.04106,011,166.6977,207,966.31
利润总额22,045,185.76114,689,908.16105,498,257.3377,141,216.31
净利润20,781,376.97106,584,102.1795,736,461.669,552,022.4
其他综合收益----
综合收益总额20,781,376.97106,584,102.1795,736,461.669,552,022.4
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,164,235,983.151,051,029,837.06995,438,366.731,261,158,032.68
非流动资产合计2,257,051,203.282,268,521,835.652,299,646,480.152,068,875,842.52
资产总计3,421,287,186.433,319,551,672.713,295,084,846.883,330,033,875.2
流动负债合计587,760,063.24505,841,421.41536,381,037.93599,094,892.04
非流动负债合计503,997,860.39504,962,365.47449,338,342.76448,975,164.79
负债合计1,091,757,923.631,010,803,786.88985,719,380.691,048,070,056.83
归属于母公司股东权益合计2,329,529,262.82,308,747,885.832,309,365,466.192,281,963,818.37
股东权益合计2,329,529,262.82,308,747,885.832,309,365,466.192,281,963,818.37
负债和股东权益合计3,421,287,186.433,319,551,672.713,295,084,846.883,330,033,875.2
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计180,880,374.54884,393,804.35521,186,224.17359,006,670.49
经营活动现金流出小计145,216,119.32599,204,109.96359,022,399.92274,010,480.25
经营活动产生的现金流量净额35,664,255.22285,189,694.39162,163,824.2584,996,190.24
投资活动现金流入小计83,354,339.0977,846,960.0360,297,42759,590,788.18
投资活动现金流出小计67,264,490.43583,499,893.25521,271,504.37268,019,038
投资活动产生的现金流量净额16,089,848.66-505,652,933.22-460,974,077.37-208,428,249.82
筹资活动现金流入小计164,580,000891,487,338.8658,487,338.8569,135,184
筹资活动现金流出小计85,871,770.281,002,461,092.97740,894,705.77536,994,727.75
筹资活动产生的现金流量净额78,708,229.72-110,973,754.17-82,407,366.9732,140,456.25
汇率变动对现金及现金等价物的影响339,655.944,046,855.024,760,520.454,075,239.22
现金及现金等价物净增加额130,801,989.54-327,390,137.98-376,457,099.64-87,216,364.11
期末现金及现金等价物余额296,214,227.3165,412,237.76116,345,276.1405,586,011.63
最新报告期:2025-05-15
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信证券陈竹,王凯旋,韩世通0.270.330.392025-05-15
华创证券郑辰,王宏雨0.290.350.422025-05-04
太平洋周豫,乔露阳0.270.350.472025-04-24
TOP↑